EUVIMEDEUVIMED entdecken
Crossref

The invisible burden of multiple sclerosis: neuropsychiatric presentations and clinical pharmacology challenges

Mehmet Hamamcı

Academic Journal of Neuropsychiatry and Neuropsychology · 2026

DOI: 10.51271/ajnn-0056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Academic Journal of Neuropsychiatry and Neuropsychology, 2026. Verfasst von Mehmet Hamamcı.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) is a chronic central nervous system disease in which inflammation, demyelination, and neurodegeneration play interconnected roles. Successful MS management is not limited solely to suppressing inflammation. Early recognition of psychiatric presentations and meticulous planning of psychopharmacological interventions are essential. A strong multidisciplinary collaboration among neurologists, psychiatrists, and pharmacologists will alleviate the mental burden of the disease and minimize pharmacological morbidity. To enhance quality of life and long-term treatment success, there is an urgent need for comprehensive clinical guidelines that address this intersection.

Zitieren

APA

Hamamcı, M. (2026). The invisible burden of multiple sclerosis: neuropsychiatric presentations and clinical pharmacology challenges. Academic Journal of Neuropsychiatry and Neuropsychology. https://doi.org/10.51271/ajnn-0056

Vancouver

Hamamcı M. The invisible burden of multiple sclerosis: neuropsychiatric presentations and clinical pharmacology challenges. Academic Journal of Neuropsychiatry and Neuropsychology. 2026. doi:10.51271/ajnn-0056

BibTeX
@article{Hamamc2026,
  author = {Hamamcı, Mehmet},
  title = {The invisible burden of multiple sclerosis: neuropsychiatric presentations and clinical pharmacology challenges},
  journal = {Academic Journal of Neuropsychiatry and Neuropsychology},
  year = {2026},
  doi = {10.51271/ajnn-0056}
}
Kostenlos starten →